To study changes in the ribosomes of afferent-deprived NM neurons, we obtained a monoclonal antibody to ribosomal RNA. This monoclonal antibody, Y 106, labels ribosomes of all NM neurons receiving normal synaptic activity. Following removal of afferent input, NM neurons demonstrate a biphasic change in their pattern of Y 1 OB label. During the initial phase, there is a uniform decrease in the density of YlOB label. In the second phase, some NM neurons recover the capacity to bind the YlOB antibody while others remain unlabeled.
During this second phase, NM neurons putatively destined to die, based on their failure to synthesize protein, are unlabeled by the YlOB antibody. New gene expression is not necessary to initiate the change in ribosomal immunoreactivity that leads deafferented NM neurons toward cell death. Blocking cytoplasmic protein synthesis with cycloheximide had no effect on the biphasic change in Y 108 labeling of afferent-deprived NM neurons. Treating chicks with chloramphenicol, however, prevented the recovery of YlOB immunoreactivity in NM neurons during the second phase of the response to afferent deprivation.
[Key words: neuronal death, afferent deprivation, nucleus magnocellularis, ribosome, mitochondria, protein synthesisJ
Neurons in the neonatal chick cochlear nucleus, nucleus magnocellularis (NM), exhibit nearly simultaneous activation of survival and suicide mechanisms in response to loss of afferent input from the eighth nerve. Following deafferentation or blockade ofafferent excitatory activity, NM neurons in young animals undergo a series of rapid intracellular changes that eventually result in the death of 20-40% of the population (Rubel et al., 1990) . Decreased protein synthesis, measured by incorporation of 3H-leucine, is an early response of NM neurons to afferent deprivation (Steward and Rubel, 1985; Born and Rubel, 1988) . Following loss of afferent input, all NM neurons demonstrate decreased 'H-leucine incorporation, but by 6 hr, two distinct populations of NM neurons can be identified. One population continues to incorporate 'H-leucine at a rate slightly reduced from normal, while the remainder appear to cease entirely incorporation of the amino acid label. Several lines of evidence suggest that those NM neurons that have ceased protein synthesis 6 hr after cochlea removal are the cells that will eventually die (Rubel et al., 1991) . For example, electron microscopic evidence shows complete ribosomal destruction in those cells that are no longer synthesizing protein 6 hr following deafferentation (Rubel et al., 199 1) . Despite these degradative changes, if synaptic activity is restored after 6 hr of afferent activity blockade, no neuronal death ensues (Born and Rubel, 1988) .
The rapid metabolic and ultrastructural changes observed in NM neurons following the cessation of eighth nerve input support the hypothesis that an active cellular mechanism leading to neuronal death is negatively regulated by the trophic influence of afferent activity. Decreased protein synthesis (MacDonald and Cidlowski, 1982) and degradation of RNA (Cidlowski, 1982; Al Goul and Miller, 1989) have also been observed early in the process of developmental or programmed cell death in other systems. These early changes may play important roles in the series of events that eventually culminates in the death of a neuron.
Recent findings support the theory that developmental neuronal death results from an active process (Oppenheim et al.. 1990; Ellis et al., 199 1; Franklin and Johnson, 1992; Martin et al., 1992) . Like many examples of programmed cell death in non-neuronal cells. neuronal death during chick cmbryogenesis (Oppenheim et al., 1990) or in response to trophic factor deprivation ZIZ vitro (Martin et al., 1988; Scott and Davies, 1990) . appears to require new protein synthesis. These findings suggest that specific genes must be expressed in order for the cell to differentiate into a dying neuron.
Affcrent-deprived NM neurons also exhibit increased activity of enxymes involved in oxidative metabolism (Durham and Rubel. 1985; Hyde and Durham, 1990; Durham et al., 1993) . These changes are coupled with an increase in mitochondrial density, evident 6 hr after cochlea removal (Hyde and Durham, 1993b) . Inhibiting mitochondrial upregulation with the drug chloramphenicol produces an increase in the number of NM neurons that will die in response to deafferentation (Hyde and Durham, 1993a) and an increase in the number of neurons demonstrating degradation of ribosomes 6 hr after afferent dcprivation (Hartlage-Rubsamen et al., 1992) . These results are consistent with the hypothesis that the increase in mitochondrial density and oxidative function observed in affcrcnt-deprived NM neurons is an indicator of a survival mechanism involved in arresting or reversing the cell death process. Mechanisms that prevent lymphocyte apoptosis (Hockenbery et al., 1990) or programmed cell death during invertebrate neuronal development (Ellis et al., 199 1) have also been described. Overexpression of the hcl-2 gene product prevents neuronal death triggered during normal development (Vaux et al., 1992) or trophic factor deprivation (Garcia et al., 1992) . Little is known about the molecular or enzymatic function of the hcl-2 gene product. The localization of this protein to mitochondria, however, suggests that the cell survival program that it promotes may involve that organelle system. Bidirectional regulation of the cell death phenotype is suggested by the existence of a survival mechanism.
In such a scheme. the ultimate fate of a cell is determined by the balance between the influences of the suicide program and of the opposing survival mechanisms. To elucidate further the biochemical mechanisms involved in the theorized survival and suicide programs, inhibitors of cytoplasmic and mitochondrial protein synthesis could be employed. However. marking the neuronal death process in NM entailed cumbersome 'H-leucine autoradiography to demonstrate decreased ribosomal function or electron microscopic evidence of ribosomc degradation or dissociation. We hypothesized that an antibody to ribosomal RNA (rRNA) may be a more useful marker of the extent of rRNA degradation in these cells. A monoclonal antibody to rRNA, Y 1 OB, had been generated from a genetic mouse model of autoimmune disease (Lemer et al., 1981) . The Y 101~ antibody immunoprecipitates whole ribosomes as well as all sizes of phenol-extracted rRNA, indicating that it recognizes a nucleic acid motifcommon to many rRNAs (Lemer et al., 198 1; G. Garden, E. Rubel, and M. Bothwell. unpublished observations) . Using the Y 1 OB antibody as a marker of those cells undergoing ribosome degradation, we addressed three questions regarding the process of afferent-deprivation-induced cell death in NM neurons. First, we examined whether altered Y 1 OB immunoreactivity could be used to identify neurons undergoing the metabolic sequence of events leading to cell death. Second, we cxamined whether the changes in rRNA immunoreactivity resulted from the induction ofgenes not constilutively expressed in these neurons. Third, we examined whether blocking mitochondrial protein synthesis with chloramphenicol treatment would alter the pattern of change in Y 1 OB immunoreactivity normally observed in affercnt-deprived NM neurons.
Materials and Methods Animals
All experimental and control animals were lo-14- The right cochlea was removed according to the method of Born and Rubel (1985) .
Briefly, chicks wcrc deeply anesthetized with ketamine (80 mg/kg body weight) and sodium pentobarbital (15 mg/kg body weight).
Two 5 mm incisions were made to widen the external ear canal. With a pair of #5 Dumont forceps the tympanic membrane was punctured, the middle ear ossicle removed and the cochlea pulled out through the oval window. The cochlea was examined under a dissecting microscope to ensure the complete removal ofthe receptor organ. The middle ear cavity was then filled with Gelfoam, and the external incisions were cleaned and closed with cyanoacrylate adhesive. This procedure leaves the cell bodies and proximal axons of eighth nerve ganglion cells intact. The ganglion cells begin to degencratc 12-18 hr later (Born and Rubel, 1985) .
Eighth nerve activity blockade. Electrical activity in the eighth nerve was silenced unilaterally by intralabyrinthine placement of TTX according to the method of Canady and Rubel(1992 (Born and Rubel, 1988; Canady and Rubel, 1992 In later studies, the Y IOB hybridoma was obtained and a large quantity of supernatant with a high concentration of antibod) was generated in cell culture facililies at the University of Washington.
All solutions m the immunohistochemlstry procedure were prepared m PBS with I % bovine serum albumin (BSA) and 0.1% sodium azide. Dcparaffinized sections were rehydrated through graded alcohols then incubated with 4% horse serum for 1 hr and then incubated with a I:5000 dilution of YIOB ascites or a I:500 dilution of 3upcrnatant from cultures of the YIOB hybridoma. Incubation with the primary antibod) was carried out overnight at room temperature in a humidified chamber.
After three washes (10 min The BIOQUANT image analysis program was first set to a densit) threshold that recognized only the black area of the digitized image, which represented the silver grains. The DAB reaction product was represented in the digitized image by grays with a density below the threshold set for the silver grains. Both the nuclear area and the area of the silver grains were then subtracted from the area used to determine the optical density of the YlOB label in the cytoplasm of each NM neuron in both sides of the section.
Statzstical analysis. The quantitative and statistical analyses are similar to those described in detail in earlier publications (Born and Rubel, 1988; Hyde and Durham, 1990 visually as unstained by Y 1 OB immunohistochemistry and the proportion of NM neurons that will eventually be lost from the nucleus.
Results

Two phases of change in YIOB immunoreactivity
To examine the ability of an antibody that recognizes rRNA to label the structural changes in ribosomes seen in NM neurons following afferent deprivation, tissue from animals killed 3, 6, 9, or 12 hr following cochlea removal was stained with the Y 1 OB antibody using conventional DAB immunohistochemistry. The Y 10B antibody labels the cytoplasm of every neuron in the normal brainstem with a granular pattern indicative of ribosomal staining (Fig. 1) . Many glial cells, choroid cells, and meningeal cells are also labeled by this antibody. There are differences in the amount of YlOB label in different neuronal populations, but the neurons within specific nuclei are usually labeled to a similar extent. Neuronal and glial nuclei are not labeled by the Y 1 OB antibody and one paradoxical aspect of the staining pattern is that the nucleolus, which contains a high concentration of rRNA, also does not label. Intact NM neurons demonstrate a fairly uniform amount of Y 1 OB immunoreactivity.
Following the removal ofafferent input, NM neurons undergo a biphasic change in their staining for the Y 10B antibody (Fig.  2) . During the first phase, 3 hr after cochlea removal, nearly every afferent-deprived NM neuron demonstrates decreased rRNA immunoreactivity, while in the second phase, 6-12 hr following cochlea removal, two distinct populations of afferentdeprived NM neurons develop. Photomicrographs of Y 10B stained NM neurons 3 and 12 hr following cochlea removal are shown in Figure 2 . The bottom photomicrograph of each pair is of NM neurons from the side of the brain ipsilateral to the cochlea removal, and pictured above are cells from the intact NM of the same tissue section (contralateral to the cochlea removal). At the 3 hr time point ( Fig. 2A,B) , nearly all afferentdeprived NM neurons exhibit a decrease in Y 1 OB immunolabel. The pattern of the remaining immunoreactivity is limited to a thin rim along the cytoplasmic membrane. By 12 hr after cochlea removal (Fig. 2C, D Representative distribution plots (Fig. 3 ) from individual animals killed 3, 6, and 12 hr following cochlea removal illustrate how the OD of Y 1 OB immunolabel in NM neurons changes after loss of synaptic input. These distribution plots were constructed by binning the number of NM neurons within an OD z-score range of 0.5 and plotting the number of neurons in each bin on the y-axis against the z-score of that bin on the x-axis. In each animal it can be seen that the contralateral NM neurons (solid. bars) demonstrate a normal distribution of z-scores centered around the mean, which has a z-score of zero. The distribution of OD z-scores for deafferented NM neurons (shaded bars) is shifted to the left at 3 hr after cochlea removal but remains normally distributed. The dramatic loss of Y 1 OB immunoreactivity from the large majority of afferent-deprived NM neurons only 3 hr after cochlea removal (Figs. 2B, 3 ) was surprising in light of only modest ultrastructural evidence of ribosome destruction at this time point (Rubel et al., 199 1) . Thus, loss of Y 1 OB immunoreactivity can precede the destruction of ribosomes. During the second phase of change in ribosomal immunoreactivity, as early as 6 or 12 hr after cochlea removal, some afferent deprived NM neurons regain YlOB immunoreactivity. By 12 hr after cochlea removal, some NM neurons continue to shift to more negative z-scores, making the distribution appear rectangular or bimodal.
To determine if the shift in the distribution of Y 1 OB immunoreactivity following cochlea removal occurs similarly across several animals, the OD z-scores from each animal killed 3 or 12 hr after cochlea removal (n = 4 and 5, respectively) were grouped to generate the OD distribution plots in Figure 4 . Over 200 neurons are represented in the afferent deprived and contralateral sides in each plot of grouped data. The distribution plots of the grouped data demonstrate that the general pattern of change in OD of Y 1 OB immunolabel is consistent between animals. Bimodality of the afferent-deprived distribution at 12 hr following cochlea removal is less evident in the grouped distribution because the nadirs seen in individual distribution plots do not occur at the same z-score. In Figure 5 , the mean z-scores for Y 10B immunolabel in deafferented NM neurons 3, 6, 9, and 12 hr following loss of synaptic activation are plotted. The peak in generalized loss of Y 1 OB immunoreactivity occurs 3 hr after cochlea removal, with a mean z-score of -2.38. A one-way ANOVA demonstrated a significant decrease in mean z-score compared to unoperated controls at all four time points following deafferentation (p < 0.001).
Synaptic activity blockade
To determine whether the changes in Y 1 OB immunolabel of NM neurons following cochlea removal were due to loss of electrical activity or due to some damage mechanism that is specific to cochlea removal, a slow-release compound embedded with TTX was unilaterally implanted in the inner ear of several animals. Intralabyrinthine TTX blocks electrical activity in the eighth nerve without anatomically disrupting the auditory pathway (Born and Rubel, 1988) . The activity blockade was sustained for 3 or 6 hr, at which time the animals were sacrificed. The shift in distribution of Y 1 OB label in activity-deprived NM neurons mirrored the OD distribution shift seen following unilateral cochlea removal (Fig. 3) . Mean z-scores for Y 1 OB immunolabel of NM neurons subjected to 3 or 6 hr of eighth nerve activity blockade (-1.25 and -0.99, respectively) were not significantly different from those obtained 3 or 6 hr following cochlea removal (Student's t test, p > 0.5). These findings demonstrate that decreased Y 10B immunoreactivity results from the loss of synaptic activation, and not from degenerative changes in the eighth nerve axons. Dying neurons are marked by absence of Yl OB label Previous studies have suggested that deafferented NM neurons that will degenerate over the next 2 d are marked by their failure to incorporate 3H-leucine 6-12 hr following cochlea removal (see Discussion and Rubel et al., 1991) . To determine if those neurons that are no longer synthesizing protein are the same NM neurons that have lost their rRNA immunoreactivity, immunohistochemistry with the Y 10B antibody was performed on sections from animals that had been labeled for 3H-leucine incorporation. Following the immunolabeling procedure, the sections were coated with autoradiographic emulsion and exposed for 34 weeks. Figure 6 shows NM neurons deprived of afferent input for 6 hr that have been double-labeled by 3H-leucine autoradiography and Y 1 OB immunohistochemistry. NM neurons that no longer incorporate amino acid into protein are unlabeled by the Y 1 OB antibody. This finding is consistent in every section analyzed from these animals. However, as demonstrated in Figure 6 , there is also a subset of NM neurons that incorporated the )H-leucine label but stained lightly for the Y 1 OB antibody. These findings do not address whether those cells that label for 3H-leucine incorporation but not for YlOB will eventually regain their immunolabel or lose their ability to synthesize protein.
The mean OD z-score of the Y 1 OB label in deafferented NM neurons that fail to incorporate 3H-leucine was calculated from sections of three double-labeled animals. This subset of afferentdeprived NM neurons comprised 10-l 5% of the neurons in the experimental nucleus. In Figure 7 , the average of the mean z-scores for NM neurons not incorporating 3H-leucine from the three animals is compared with the average of the mean z-scores for those deafferented NM neurons from the same tissue section that continue protein synthesis. Those cells that incorporate 3H-leucine are modestly decreased in the level of rRNA immunoreactivity compared to neurons in the contralateral NM (averaged mean z-score = -0.95). On the other hand, Y 10B label in cells not making protein is dramatically decreased (averaged mean z-score = -4.76) compared to contralateral neurons, and is also significantly less than the amount of immunolabel in ipsilateral neurons that do incorporate the 3H-leucine (p < 0.02). These findings suggest that neurons that will eventually undergo cell death following loss of afferent input are among the pool of neurons that fail to regain rRNA immunoreactivity during the second phase of the response to afferent deprivation.
The effect of cycloheximide
To determine if the biphasic change in rRNA immunoreactivity resulted from the impact of new gene expression that might be stimulated by loss of synaptic activity, we systemically inhibited protein synthesis with the drug cycloheximide. One group of animals was treated with cycloheximide immediately prior to cochlea removal and sacrificed 3 hr later. This experiment was designed to address whether new gene expression was necessary to bring about the initial loss of rRNA immunoreactivity. A second group of animals was treated with cycloheximide beginning 6 hr after cochlea removal and sacrificed 3 hr later. By preventing protein synthesis during this phase, we hoped to determine if newly synthesized proteins were required for the development of a bimodal distribution of Y 1 OB label. Figure  8A shows the results of both experiments with mean z-scores for cycloheximide-treated and untreated controls 3 or 9 hr after cochlea removal. Student's t tests show no significant difference between mean z-scores for cycloheximide-treated and untreated animals at either time point.
In order to examine the population of neurons with very low Y 1 OB immunoreactivity, the percentage of neurons unlabeled with the Y 1 OB antibody was determined for each animal by designating any neuron with an OD outside the 95% confidence interval of the contralateral distribution (z-score < -2.0) as a Y 1 OB-negative cell. Figure 8B displays the portion of Y 1 OBnegative neurons in NM 3 or 9 hr after cochlea removal from cycloheximide-treated and untreated animals. There was no effect of cycloheximide treatment on the proportion of YlOBnegative neurons at either time point. These experiments demonstrate that cycloheximide treatment had no effect on either the initial decrease in total Y 1 OB immunolabel or the eventual distribution of that label into two populations of deafferented NM neurons. These findings indicate that the decrease in rRNA immunoreactivity following loss of synaptic input does not depend on changes in gene expression. Additionally, the ability of some NM neurons to regain rRNA immunoreactivity during the second phase of the response to afferent deprivation was not inhibited by cycloheximide treatment. The effect of chloramphenicol
To study the impact of inhibiting the upregulation of mitochondria (Rubel et al., 1990; Hyde and Durham, 1993a) on the temporal pattern of change in rRNA immunoreactivity in afferent-deprived NM neurons, chicks were treated with chloramphenicol, an inhibitor of mitochondrial protein synthesis. Chloramphenicol or vehicle was administered continuously at the rate of 1000 mg/kg/d until the animals were sacrificed 3, 6, or 12 hr after deafferentation. Figure 9 , A and B, demonstrates Y 1 OB-labeled NM neurons from the intact (A) and afferentdeprived (B) sides of the auditory brainstem 12 hr following cochlea removal from an animal treated with chloramphenicol. Compared to animals receiving cochlea removal and no drug treatment (Fig. 2) , there is a dramatic increase in the number Chloramphenicol treatment prevents the development of and killed at either 3,6, or 12 hr lhllowinn cochlea removal. Note failure a Y 10B labeled population of afferent-deprived NM neurons at 6 or 12 of most ipsilateral neurons (solid bars) io recover enough Y 1OB label hr after cochlea removal. Shown here are distribution plots similar to to obtain an OD z-score in the normal contralateral distribution at 6 those in Figure 3 from individual animals treated with chloramphenicol or 12 hr following cochlea remo\ al. of neurons that fail to regain Y 1 OB immunoreactivity.
Chloramphenicol treatment prevents the development of a bimodal OD distribution.
OD distribution plots from representative animals in the chloramphenicol treatment groups are displayed in Figure 10 . Three hours after cochlea removal, the shift to the left in the OD distribution of afferent-deprived NM neurons is similar to the shift in untreated animals (see Fig. 3 ). The only change from the 3 hr OD distributions of untreated animals is that the afferent-deprived OD distribution is further shifted to more negative z-scores. The OD distributions from chloramphenicol-treated animals 6 and 12 hr following cochlea removal, however, are markedly different from the OD distributions of untreated animals (Fig. 3) . The 6 and 12 hr OD distribution plots from chloramphenicol-treated animals demonstrate that very feu cells are able to regain normal rRNA immunoreactivity.
In Figure 11 , the mean percentage of Y 1 OB-negative cells (zscore < -2.0) from animals treated with chloramphenicol and sacrificed 3. 6. or 12 hr following cochlea removal is compared to the mean percentage of Y 1 OB-negative neurons in vehicletreated controls. The portion of NM neurons that remain unlabeled by the Y 1 OB antibody 6 and 12 hr after cochlea removal is significantly elevated by the chloramphcnicol treatment (twoway ANOVA shoned a reliable effect of treatment: p < 0.02). Post hoc comparisons using Duncan's New Multiple Range test showed a significant elevation in the number of Y lOB-negative neurons at both 6 hr (11 < 0.00 1) and 12 hr (I-< 0.0 1) following cochlea removal. Chloramphenicol treatment produced no significant change in the percentage of YlOB-negative neurons 3 hr after cochlea removal. Thcsc findings suggest that chloramphenicol treatment. Ivhich is known to increase the amount of deaffcrcntation-induced neuronal death in NM neurons (Hyde and Durham, 1993a) , may act by preventing NM neurons from recovering rRNA immunoreactivity and allowing a greater portion of the cells to continue along the cell death path\vay. 
Discussion
In this study we report a new measure of the cell death process i n neurons of the affcl-cnt-deprived chick cochlear nucleus and explore how it is affected by cytoplasmic or mitochondrial protein synthesis inhibition.
Our findings indicate that in response to loss of synaptic input, NM neurons demonstrate an initial decrease in immunoreactivity for the rRNA cpitopc recognized by the Y IOB antibody. In the second phase of this response, some NM neurons are capable of regaining rRNA immunoreactivity, while others become completely Y IOB-negative. The correlation between the lack of Y 1 OB label and failure to incorporate 'H-leucine supports the hypothesis that cells destined to die are among those that fail to regain rRNA immunoreactivity 6 hr after cochlea removal. Preventing new gene exprcssion through inhibition of cytoplasmic protein synthesis had no impact on the extent ofinitial loss or eventual recovery ofrRNA immunoreactivity in afferent-deprived NM neurons. C'hloramphenicol blockade of the uprcgulation i n oxidative capacity normally observed following loss of synaptic input to NM neurons prevents the recovery of rRNA immunoreactivity during the second phase of the response to afferent deprivation.
The remainder of this discussion will address several issues related to these data. First. the questions of what role changes in ribosome structure, as reflected by Y 1013 immunoreactivit>, play in the cell death process and how these changes may relate to other types of neuronal death will bc addressed. Second, the hypothesized cell survival process evoked in NM neurons by affcrent deprivation will be discussed. Third. the Intracellular signals that may be involved in initiating the changes in rRNA immunoreactiylty mill be considered. Finall). MC w-ill present our current working model of the intracellular responses to loss of afferent input in NM neurons.
Immunotabeling afferent-deprived NM neurons with a monoclonal antibody to rRNA, Y lOB, demonstrates an intriguing temporal pattern in the immunoreactivity of ribosomes. There is an initial shift in the entire population of NM neurons to decreased levels of rRNA immunorcactivity 3 hr after cochlea removal. Liltrastructural studies have shown only a modest toss of ribosomes from endoplasmic reticulum at this time point, in only a small portion of NM neurons (Rubel et al.. 1991) . Our findings indicate that decreased ribosomal immunorcactivity precedes ultrastructural evidence ofribosomc destruction in most afferent-deprived NM neurons. This suggests that some discrete modification ofrRNA that alters the Y I OB epitopc occurs prior to the actual destruction of the ribosome. Alternatively, decreased nuclear production of rRNA might contribute to a slow loss of rRNA immunoreactivity in the presence or normal or accelerated ribosomc turnover.
In addition to marking an alteration of ribosomc structure in afferent-deprived NM neurons, the loss or Y t OB immunoreactivity seems to mirror the decrease in ribosome function that has been observed in previous studies. Protein synthesis initially decreases in all affercnt-deprived NM neurons with an eventual segregation into two populations of cells: those that incorporate slightly less amino acid than control NM neurons. and those that cease protein synthesis entirely (Steward and Rubel, 1985; Born and Rubel. 1988; Rubel et al.. 199 1) . The initial dccrcase in protein synthesis is secondary to a loss of synaptic input from the eighth nerve and cannot bc reversed b> antidromic dcpolarization of NM neurons (Hyson and Rubel. 1989) . Likewise, YlOH immunorcactivity is specifically regulated by afferent synaptic activity, and antidromic electrical stimulation will not pre\.ent the loss of immunorcactivitl associated with afrerent deprivation (Hyson and Rubel, 1992) . These parallel changes in ribosomc structure and function suggest that the structural alteration of the ribosomc recognized by the Y 10B antibody ma) produce the change in ribosome function measured by 3H-amino acid incorporation.
By 6 hr after cochlea removal. NM neurons have segregated into two populations based on rRNA immunoreactivity, ribosomal ultrastructure (Rubel et at.. 199 l) , and the capacity to synthesize protein (Steward and Rubel, 1985; Born and Rubel, 1988) . T\vo lines of evidence suggest that regulation of ribosomal structure and function may be an important component ofthe neuronal death process in NM. First, failure to incorporate 'H-tcucine 6 hr following cochlea rcmov-al is also strong11 cor-I-elated with eventual ccl1 loss (Steward and Rubet. 1985: Rubel et al., 199 1; E. W. Rubet and 0. Steward, unpublished observations) , suggesting that ribosomc dissociation and lack of rRNA immunoreactivity may be markers of the dying population of afferent-deprived NM neurons. Second. chloramphenicol treatment. which increases the amount of neuronal death in the affercnt-deprived NM (Hyde and Durham. 1993a) , also increascs the portion of NM neurons that demonstrate lack of rRNA immunoreactivity and ribosomc dissociation (Hartlage-Rubsamcn et al.. 1992) .
Ribosomc dissociation and destruction have been reported in several other types of neuronal death. including deafferentation-induced cell death in olfactory cortex of rats (Heimcr and Kalil. 1978) . developmental neuronat death in chick motor neurons (Chu-Wang and Oppenheim. 1978) , chick ciliary ganglion neurons (Pilar and Landmcsser, 1976) . and rat retina (Cunningham, 1982) and the ventral ganglia of the moth Munduca .SCXU during adult metamorphosis (Stocker ct al., 1978) . There are also reports of ribosome dissociation in neurons undergoing delayed neuronal death following ischemia (Petit0 and Pulsineti. 1984; Yamamoto et al., 1990) or exposure to toxic levels of glutamate in the absence of serum growth f%tors in viftv (Dux ct al., 1992) . None of these reports has directly linked early changes in the ultrastructure of neuronal ribosomes to e\ entual cell death by what has been labeled an apoptotic mechanism, w-hich includes chromatin condensation and DNA cleavage (Wqllie et al., 1984; Uarkc, 1990) . However, ribosomc dissociation has been reported as an early step in the cell death process of a preglial ccl1 line, serum-free mouse embryo cells, which eventual11 die by a process that closely resembles the nuclear changes seen in apoptosis (Rawson et al.. 1991) . Additionall). chromatin condensation produces pyknotic nuclei, which are commonly observed in developing chick ventral spinal cord during developmental motor neuron death when some ofthcse neurons also exhibit a loss of ribosomes (C'hu-Wang and Oppenhcim. 1978; Oppcnheim et at., 19YO) . Our approach has been to study the earliest events following the loss of synaptic activation in order to establish whether a neuron's initial response may be to turn on a cell death program.
Causal links between early changes in dying neurons like ribosome degradation and the later development of an apoptotic morphology or the eventual death of the neurons may be even more elusive to identify. Application of the Y 1013 antibody to additional neuronal populations and during other types of neuronal death. such as occurs during normal development, after growth factor deprivation and following ischemic or excitotonic injury. may help to answer many questions about the role of ribosomcs in neuronal death.
A second phase in the response of NM neurons to afferent deprivation involves recovery of rRNA immunoreactivity in a subpopulation of neurons. Recovery of rRNA immunoreactivity appears to mark NM neurons that will survive deafferentation. This is suggested by the ability of all Y lOB-positive cells to incorporate 'H-leucine 6 hr after cochlea removal. In addition, the size of the YIOB-negative population after 12 hr of afferent deprivation approximates the size ofthe population that will eventually die. We find that the recovery of rRNA immunorcactivity can be prevented by using chloramphcnicol to block the ability of a deaffci-ented neuron to increase oxidativc metabolism and mitochondrial density. Previous studies from our laboratory hav-e demonstrated that chloramphenicol treatment for the first 12 hr of alferent deprivation will produce a large increase in the number of NM neurons that have degenerated by 5 d after cochlea removal (Hyde and Durham. 1993a) . Ultrastructural studies of afferent-deprived NM neurons from chloramphcnicol-treated animals have also demonstrated that there is a significant increase in the number of cells that demonstrate complete ribosomal degradation at 6 or 12 hr following cochlea removal (Hartlage-Rubsamcn et al., 1992) . There are two implications of the finding that chloramphenicol treatment produces an increase in the proportion of NM neurons that display the same early changes as those seen in neurons subjected to aI%rent deprivation alone. First. the lack of a pathologic process separate from the one seen with affercnt deprivation alone suggests that the increased cell death induced by chloramphenicol results from the mechanisms associated with afferent deprivation.
and not through a separate toxic interaction between chloramphenicol and loss of synaptic input. Second, these findings suggest that the cell death process involving ribosomc destruction and the ccl1 survival process involving mitochondrial upregulation are two distinct and opposing responses to deafferentation. This hypothesis is supported by the finding that the cell survival process can be attenuated by inhibition ofmitochondrial upregulation while the cell death process continues.
Two issues are raised by a putativ,e cell survival program involving the upregulation of mitochondrial function. The hnding that mitochondrial function is an important component of the ccl1 surviv-al process is intriguing in light of reports that the proto-oncogenc hc/-2, which prevents programmed cell death. is localized to mitochondria (Hockcnbery et al., 1990; Monaghan et al.. 1992) . The normal cellular function of bcl-2 is unknown. However, overexpression of 1~1-2 can prevent apoptotic cell death even in the absence of mitochondria (Jacobson et al., 1993) . Several authors have demonstrated that bcl-2 is also associated with nuclear membrane and endoplasmic reticulum (Chen-Levy et al., 1989 : Alncmri et al., 1992 Jacobson et al., 1993) . It is possible that the two organellc systems most prominent in NM neuronal death may be linked by the function of ljcl-2. Efforts to determine if bcl-2 expression is altered by deafcrentation arc ongoing in our laboratory. The second issue suggested by the presence of a cell survi\,al program concerns the function that this program plays during the critical period of development when neurons arc susceptible to loss of afferent input. It has been recognized for many years that neurons in young animals appear to be more susceptible to affcrent deprivation, target cell removal, axotomy, or other insults (Cowan. 1970; Globus, 1975; Kalil, 1980; Hashisaki and Rubel. 1989; Snider et al., 1992) . Future studies should address the question of whether an increase in the relative influence of the cell survival program with maturity may account for the differential effects of afferent deprivation or other insults in young versus adult animals.
Several investigators
of neuronal death during development or following trophic factor deprivation in 1'2~0 have found that inhibition oftranscription or translation may prevent cell death (Martin et al.. 1988; Oppenheim et al., 1990; Scott and Davies, 1990; Edwards et al., 199 1) . These studies suggest that the cell death signal is transduced at the level of the nucleus through alterations in gene expression. However. there are se\-era1 recent examples of other cell types in which physiologic cell death and survival are regulated independent of macromolecular synthesis (Rukenstein et al.. 199 1; Owens and Cohen. 1992) . In this study. we demonstrate that new protein synthesis is not necessary to induce the initial changes in ribosome immunoreactivity or for the eventual recovery of rRNA immunoreactivity.
Thus, the dramatic changes in ribosomal structure and function during the first 3-9 hr after afferent deprivation are initiated by enzymes constitutively expressed in NM neurons of young animals. These findings, in conjunction with other examples of physiologic cell death that are not dependent on protein synthesis. suggests that transduction of a cell death signal may take place outside of the nucleus in some cell types.
Several signal transduction mechanisms that do not directly involve alteration of gene expression have been implicated in the physiologic death of neuronal cells. c4MP and CAMP analogs can promote neuronal survival of NGF-deprived PC12 cells (Rukenstein et al., 1991) , cultured retinal ganglion cells subjected to a blockade of alferent synaptic activity with TTX (Kaiser and Lipton, 1990) and NGF-deprived. cultured sympathetic neurons (Edwards et al., 1991 : Martin et al.. 1992 . Another second messenger involved in preventing neuronal death is cytosolic fret Ca' ' (Franklin and Johnson, 1992) . Ca' i influx through voltage-dependent CaZ' channels or Ca' ' release from intracellular stores can prevent the death of NGF-deprived sympathetic neurons in culture (Kioke et al., 1989) . The ras protooncogene also promotes neuronal survival, even in the absence of neurotrophic factors, when an oncogenically activated form is introduced into cultured neurons (Borasio et al., 1989) . These three intracellular effecters, CAMP, Ca2-and ras, can influence the activity of intracellular protein kinascs. It is possible that removal ofafferent activity from NM neurons produces achange in the activation of protein kinases, and that the subsequent alteration of protein phosphorylation induces the early changes observed in ribosomes during the cell death process.
A rnodcl of an R-M neuror~'.s rrsponse to ufikrent deprivation
The hndings prcscnted here, in conjunction with previous studies of afferent-deprived NM neurons, support a general model of the early response in NM neurons to the loss of afferent innervation. rons. Changes associated with the initial response to afferent deprivation include decreased incorporation of amino acids into protein (Steward and Rubel, 1985; Born and Rubel, 1988; Hyson and Rubel, 1989 ) modest structural change in the organization of ribosomes on rough endoplasmic reticulum (Rubel et al., 1991) , and the decreased immunoreactivity for rRNA reported in this study. During the second phase of the response to afferent deprivation, NM neurons tend to segregate into two populations. We have designated the two populations of neurons as exhibiting type S (survival) or type D (degeneration) responses, shown schematically in the 6-12 hr column of the diagram. A type S response involves the return of immunoreactivity for rRNA, attenuation of the loss of protein synthetic capacity, increased activity of oxidative enzymes and increased mitochondrial density. A cell's ability to mount a type S response is altered by the action of chloramphenicol. Chloramphenicol treatment prevents two components of the type S response: mitochondrial upregulation and return of rRNA immunoreactivity, and increases the portion of afferent-deprived NM neurons that eventually die. These findings suggest that the type S response represents the path toward survival of an afferentdeprived NM neuron.
The type D response includes cessation of protein synthesis, continued loss of rRNA immunoreactivity, and complete ribosomal degradation. It should be noted that up to 12 hr after afferent deprivation is initiated, the return of synaptic input (broken arrows in Fig. 12 ) can "save" cells that have already mounted a type D response (Born and Rubel, 1988) . If the functional deafferentation is extended beyond approximately 12 hr, we hypothesize that neurons that demonstrate a type D response will eventually die and be removed from the nucleus, presumably by phagocytic action of surrounding non-neuronal cells. Currently, there is little knowledge ofwhat occurs between 12 hr after cochlea removal and 48-72 hr when the dying neurons disappear from the nucleus.
If an NM neuron survives deafferentation, rRNA immunoreactivity returns to normal levels (G. A. Garden and E. W Rubel, unpublished observations) whereas oxidative enzyme activity is permanently decreased (Durham and Rubel, 1985; Hyde and Durham, 1990; Durham et al., 1993) . Mitochondrial density in deafferented NM neurons decreases to a level below control NM neurons by 2 weeks following cochlea removal (Hyde and Durham, 1993b) . These changes in oxidative metabolism and mitochondria probably reflect the decreased metabolic activity required for electrically silent and atrophied neurons. Another lasting change in NM neurons that survive the loss of synaptic activity is a reduction in perikaryal volume by approximately 30110% (Born and Rubel, 1985) .
Loss of synaptic input to NM neurons causes all of the cellular events outlined above. The extent to which the mechanism for any of the changes demonstrated in afferent-deprived NM neurons is recapitulated in other neuronal death paradigms is not known. However, it is unlikely that this question can be adequately addressed until more specific knowledge is generated on the molecular events involved in producing the changes in oxidative metabolism or ribosome structure and function. With markers of these changes that have been developed recently or are currently being developed, the avian brainstem auditory system appears well suited for investigating the interaction between cellular events leading to neuronal death and neuronal survival following afferent deprivation.
